ArticleCancers2022

Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus.

Sascha Hoppe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.